[1]
|
K. E. Sharquie, “Vitiligo,” Clinical and Experimental Dermatology, Vol. 9, No. 2, 1984, pp. 117-126.
doi:10.1111/j.1365-2230.1984.tb00772.x
|
[2]
|
K. E. Sharquie, “The Histology and Immunopathology of Vitiligo,” Ph.D. Thesis, University of Sheffield, Sheffield, 1982.
|
[3]
|
K. E. Sharquie, S. H. Mehenna, A. A. Naji and H. Al-Azzawi, “Inflammatory Changes in Vitiligo: Stage I and II Depigmentation,” The American Journal of Dermatopathology, Vol. 26, No. 2, 2004, p. 108.
doi:10.1097/00000372-200404000-00004
|
[4]
|
M. B. Abdel-Naser, S. K. Hann and J. C. Bystryn, “Oral Psoralen with UV-A Therapy Releases Circulating Growth Factors that Stimulates Cell Proliferation,” ARCH Dermatology, Vol. 133, No. 12, 1997, pp. 1530-1533.
doi:10.1001/archderm.1997.03890480050007
|
[5]
|
S. Malakar and S. Dhar, “Repigmentation of Vitiligo Patches by Transplantation of Hair Follicles,” International Journal of Dermatology, Vol. 38, No. 3, 1999, pp. 237-238.
|
[6]
|
R. Falabella, “Surgical Therapies for Vitiligo and Other Leukoderma, Part 1: Minigrafting and Suction Epidermal Grafting,” Dermatologic Therapy, Vol. 14, No. 1, 2001, pp. 7-14. doi:10.1046/j.1529-8019.2001.014001007.x
|
[7]
|
K. E. Sharquie, “Pigment Minigrafting as Treatment for Dermatomal Vitiligo,” The 9th Scientific Congress, College of Medicine, University of Baghdad, Baghdad, 1996.
|
[8]
|
M. Ozdemir, O. Cetinkale, R. Wolf, A. Kotogyan, C. Mat, B. Tuzun and Y. Tuzun, “Comparison of Two Surgical Approaches for Treating Vitiligo: A Preliminary Study,” International Journal of Dermatology, Vol. 41, No. 3, 2002, pp. 135-138. doi:10.1046/j.1365-4362.2002.01391.x
|
[9]
|
A. M. Kahn and M. J. Cohen, “Treatment by Dermabrasion and Epithelial Sheet Grafting,” Journal of the American Academy of Dermatology, Vol. 33, No. 4, 1995, pp. 646-648. doi:10.1016/0190-9622(95)91287-8
|
[10]
|
K. Agrawal and A. Agrawal, “Repigmentation with Dermabrasion and Thin Split-Thickness Skin Graft,” Dermatologic Surgery, Vol. 21, No. 4, 1995, pp. 295-300.
doi:10.1016/1076-0512(94)00002-8
|
[11]
|
S. V. Mulekar, “Long-Term Follow-Up Study of 142 Patients with Vitiligo Vulgaris Treated by Autologous, Non-Cultured Melanocyte-Keratinocyte Cell Transplantation,” International Journal of Dermatology, Vol. 44, No. 10, 2005, pp. 841-845.
doi:10.1111/j.1365-4632.2005.02226.x
|
[12]
|
S. V. Mulekar, A. Al Issa and A. Al Eisa, “Treatment of Vitiligo on Difficult-To-Treat Sites Using Autologous Non-cultured Cellular Grafting,” Dermatological Surgery, Vol. 35, No. 1, 2009, pp. 66-71.
doi:10.1111/j.1524-4725.2008.34384.x
|
[13]
|
S. V. Mulekar, “Stable Vitiligo Treated by a Combination of Low-Dose Oral Pulse Betamethasone and Autologous, Melanocyte-Keratinocyte Cell Transplantation,” Dermatologic Surgery, Vol. 32, No. 4, 2006, pp. 536-541.
doi:10.1111/j.1524-4725.2006.32109.x
|
[14]
|
S. V. Mulekar, B. Ghwish, A. Al Issa and A. Al Eisa, “Treatment of Vitiligo Leasions by ReCell vs. Conventional Melanocyte-Keratinocyte Transplantation: Pilot Study,” Journal of the European Academy of Dermatology and Venereology, Vol. 158, No. 1, 2008, pp. 45-49.
|
[15]
|
B. M. El-Zawahry, N. S. Zaki, D. A. Bassiouny, R. M. Sobhi, A. Zaghloul, M. M. Khorshied and H. M. Gouda, “Atologous Melanocyte-Keratinocyte Suspension in the Treatment of Vitiligo,” Journal of the European Academy of Dermatology and Venereology, Vol. 25, No. 2, 2011, pp. 215-220. doi:10.1111/j.1468-3083.2010.03759.x
|
[16]
|
R. Czajkowski, W. Placer, T. Drewa, B. Kowaliszyn, J. Sir and W. Weiss, “Autologous Cultured Melanocytea in Vitiligo Treatment,” Dermatologic Surgery, Vol. 33, No. 9, 2007, pp. 1027-1036.
doi:10.1111/j.1524-4725.2007.33216.x
|
[17]
|
K. E. Sharquie, A. A. Noaimi and H. A. Al-Mudaris, “Melanocytes Transplant in Patients with Vitiligo Using Needling Micrografting Technique,” Thesis for Fellowship of Iraqi Board for Medical Specializations in Dermatology and Venereology, 2012.
|
[18]
|
K. E. Sharquie, A. A. Noaimi and H. A. Al-Mudaris, “Direct Melanocytes Transplant from Normal Donor Area into Vitiliginous Recipient Area by Dermabrasion Technique,” Journal of Cosmetic, Dermatological Sciences and Application, Vol. 2, No. 4, 2012, pp. 288-293.
doi:10.4236/jcdsa.2012.24055
|
[19]
|
S. Sethi, B. B. Mahajan, R. R. Gupta and A. Ohri, “Comparative Evaluation of the Therapeutic Efficacy of Dermabrasion, Dermabrasion Combined with Topical 5% 5-Fluorouracil Cream, and Dermabrasion Combined with Topical Placentrex Gel in Localized Stable Vitiligo,” International Journal of Dermatology, Vol. 46, No. 8, 2007, pp. 875-879. doi:10.1111/j.1365-4632.2007.03226.x
|
[20]
|
N. S. Mohamed, M. F. Elgoweini and N. A. Khad, “Dermatomal Vitiligo: Therapeutic Implication of Dermabration,” Journal of Pan-Arab Leaguo of Dermatologists, Vol. 19, No. 1, 2008, pp. 21-29.
|
[21]
|
P. Redondo, A. G. Azcarate, L. Marques, M. G. Guzman, E. Andreu and F. Prosper, “Amniotic Membrane as a Scaffold for Melanocytes Transplantation in patients with Stable Vitiligo,” Dermatology Research and Practice, 2011, pp. 1-6. doi:10.1155/2011/532139
|
[22]
|
O. T. Vázquez-Martínez, H. G. Matínez-Rodríguez, L. Velásquez-Arenas, D. Banos-González, R. Ortíz-López, G. Padilla-Rivas, O. Welsh and J. Ocampo-Candiani, “Treatment of Vitiligo with a Melanocytes-Keratiocyte Cell Suspension versus Dermabrasion Only: A Pilot Study with a 12 Month Follow Up,” Journal of Drugs in Dermatology, Vol. 10, No. 9, 2011, pp. 1032-1036.
|
[23]
|
K. Agrawal and A. Agrawal, “Vitiligo: Surgical Repigmentation of Leukotrichia,” Dermatologic Surgery, Vol. 21, No. 8, 1995, pp. 711-715. doi:10.1016/1076-0512(93)00056-I
|